A clinical trial looks at whether molecular subtyping of tumors is effective in determining the best pancreatic cancer treatment.
François has been taking chemotherapy for his pancreatic cancer treatment and living one day at a time, to make the most of his life.
Because Helene Avraham-Katz has the BRCA2 mutation, certain chemotherapies work better and she is eligible for specific clinical trials.
Chris Treubert started with one type of chemotherapy but when the results of genetic testing showed a BRCA mutation he changed treatment.
Will a flexible approach to neoadjuvant treatment work better for pancreatic cancer patients with tumors that can be removed surgically?
Chemotherapy side effects can be uncomfortable. Dr. Laleh Melstrom outlines patient options for managing the various side effects for increased quality of life.